Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02757872Phase 3Completed
Phase 3, randomised, double-blind trial in Kidney disease, sponsored by Albert Einstein College of Medicine. Primary endpoint: Estimated Glomerular Filtration Rate at 4 years. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02757872.